Samsca Post-marketing General Drug Use-results Survey in Patients With Hyponatremia in SIADH
Otsuka Pharmaceutical Co., Ltd. · Antidiuretic Hormone, Inappropriate Secretion
Not applicable
Active, not recruiting
300
2026-06
Industry sponsor intelligence
Otsuka Pharmaceutical Co., Ltd.Clinical Pipeline.
Lead-sponsor view of Otsuka Pharmaceutical Co., Ltd.'s indexed peptide studies, development phases, active programs, completed work and recent registry changes.
- Total
- 1
- Recruiting
- 0
- Active
- 1
- Completed
- 0
- Results posted
- 0
- Avg enrollment
- 0
Pipeline overview
Programs by phase and activity.
Velocity
Otsuka Pharmaceutical Co., Ltd. trials by start year
Study start year · indexed snapshot
Development
Trials by phase
1phase labels
Early Phase 10
Phase 10
Phase 20
Phase 30
Phase 40
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Vasopressin → | 1 | 0 | 0 | 0 | 0 | 1 |
Active peptide trials
In motion now.
NCT IDStudyPhase / statusEnrollmentUpdated
Completed trials
Finished registry records.
No studies in this snapshot.
Search sponsor records
All Otsuka Pharmaceutical Co., Ltd. studies.
This page groups studies where Otsuka Pharmaceutical Co., Ltd. is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
1 matching study
Last registry update first
Recent updates